SGRY SURGERY PARTNERS INC revenue, earnings and financials

For the quarter ended June 30, 2026, SURGERY PARTNERS INC reported revenue of $849M (up 2.7% from a year earlier), net income of −$15.0M and diluted EPS of −$0.12; over the last four quarters revenue was $3.37B and net income −$88.6M; for the fiscal year ended December 2025 revenue was $3.31B, up 6.2% on the year before.

SGRY annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $3.31B, gross profit n/a, operating income $390M, net income −$77.9M (margin -2.4%), EPS −$0.61
• Fiscal year ended Dec 2024: revenue $3.11B, gross profit n/a, operating income $349M, net income −$168M (margin -5.4%), EPS −$1.33
• Fiscal year ended Dec 2023: revenue $2.74B, gross profit n/a, operating income $328M, net income −$11.9M (margin -0.4%), EPS −$0.09
• Fiscal year ended Dec 2022: revenue $2.54B, gross profit n/a, operating income $345M, net income −$54.6M (margin -2.2%), EPS −$0.59
• Fiscal year ended Dec 2021: revenue $2.23B, gross profit n/a, operating income $302M, net income −$70.9M (margin -3.2%), EPS −$1.12

SGRY quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $849M (up 2.7% year over year), net income −$15.0M, EPS −$0.12
• Quarter ended Mar 31, 2026: revenue $811M (up 4.5% year over year), net income −$35.9M, EPS −$0.28
• Quarter ended Dec 31, 2025 (from the annual report): revenue $885M (up 2.4% year over year), net income −$15.0M, EPS −$0.11
• Quarter ended Sep 30, 2025: revenue $822M (up 6.6% year over year), net income −$22.7M, EPS −$0.18
• Quarter ended Jun 30, 2025: revenue $826M (up 8.4% year over year), net income −$2.50M, EPS −$0.02
• Quarter ended Mar 31, 2025: revenue $776M (up 8.2% year over year), net income −$37.7M, EPS −$0.30
• Quarter ended Dec 31, 2024 (from the annual report): revenue $864M (up 17.5% year over year), net income −$109M, EPS −$0.86
• Quarter ended Sep 30, 2024: revenue $770M (up 14.3% year over year), net income −$31.7M, EPS −$0.25
• Quarter ended Jun 30, 2024: revenue $762M (up 14.2% year over year), net income −$15.5M, EPS −$0.12
• Quarter ended Mar 31, 2024: revenue $717M (up 7.7% year over year), net income −$12.4M, EPS −$0.10
• Quarter ended Dec 31, 2023 (from the annual report): revenue $735M (up 4.0% year over year), net income −$1.00M, EPS $0.00
• Quarter ended Sep 30, 2023: revenue $674M (up 8.6% year over year), net income −$4.90M, EPS −$0.04
• Quarter ended Jun 30, 2023: revenue $668M (up 8.5% year over year), net income $18.9M, EPS $0.15
• Quarter ended Mar 31, 2023: revenue $666M (up 11.7% year over year), net income −$24.9M, EPS −$0.20
• Quarter ended Dec 31, 2022 (from the annual report): revenue $707M (up 15.9% year over year), net income −$23.4M, EPS −$0.24
• Quarter ended Sep 30, 2022: revenue $621M (up 11.0% year over year), net income −$25.0M, EPS −$0.28
• Quarter ended Jun 30, 2022: revenue $615M (up 13.3% year over year), net income −$18.4M, EPS −$0.21
• Quarter ended Mar 31, 2022: revenue $596M (up 16.4% year over year), net income $12.2M, EPS $0.14
• Quarter ended Dec 31, 2021 (from the annual report): revenue $610M, net income −$100K, EPS $0.12
• Quarter ended Sep 30, 2021: revenue $559M, net income −$22.9M, EPS −$0.28

SGRY cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $274M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow $300M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow $294M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $159M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow $87.1M, share buybacks n/a

SGRY balance sheet

• Jun 30, 2026: cash $217M, total assets $8.05B, total liabilities n/a, shareholders' equity $1.67B
• Mar 31, 2026: cash $182M, total assets $8.04B, total liabilities n/a, shareholders' equity $1.69B
• Dec 31, 2025: cash $240M, total assets $8.12B, total liabilities n/a, shareholders' equity $1.71B
• Sep 30, 2025: cash $203M, total assets $7.95B, total liabilities n/a, shareholders' equity $1.73B
• Jun 30, 2025: cash $250M, total assets $7.95B, total liabilities n/a, shareholders' equity $1.75B
• Mar 31, 2025: cash $229M, total assets $7.95B, total liabilities n/a, shareholders' equity $1.74B
• Dec 31, 2024: cash $270M, total assets $7.89B, total liabilities n/a, shareholders' equity $1.79B
• Sep 30, 2024: cash $222M, total assets $7.53B, total liabilities n/a, shareholders' equity $1.90B

What is SGRY's revenue?

SURGERY PARTNERS INC reported $3.37B of revenue over its last four quarters, through June 30, 2026.

Is SGRY profitable?

No. SURGERY PARTNERS INC lost $88.6M over the last four quarters.

What is SGRY's EPS?

Diluted earnings per share over the last four quarters were −$0.69; −$0.12 in the latest quarter.

SGRY ownership and insider trades · All stocks